![A trial looking at radiotherapy and surgery for retroperitoneal sarcoma ( STRASS) | Cancer Research UK A trial looking at radiotherapy and surgery for retroperitoneal sarcoma ( STRASS) | Cancer Research UK](https://www.cancerresearchuk.org/sites/default/files/styles/cruk_wide_resp_breakpoint_one/public/9414_diagram.png?itok=M5HMIQTo)
A trial looking at radiotherapy and surgery for retroperitoneal sarcoma ( STRASS) | Cancer Research UK
![PDF) Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: Results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ... PDF) Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: Results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ...](https://i1.rgstatic.net/publication/279306365_Step-down_strategy_of_spacing_TNF-blocker_injections_for_established_rheumatoid_arthritis_in_remission_Results_of_the_multicentre_non-inferiority_randomised_open-label_controlled_trial_STRASS_Spacing_/links/561e0cc008ae50795afd890e/largepreview.png)
PDF) Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: Results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ...
Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-b
![Treatment Guidelines for Pre-operative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel EH Baldini, - ppt download Treatment Guidelines for Pre-operative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel EH Baldini, - ppt download](https://images.slideplayer.com/20/6215298/slides/slide_4.jpg)
Treatment Guidelines for Pre-operative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel EH Baldini, - ppt download
![A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2) | SpringerLink A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-023-13500-9/MediaObjects/10434_2023_13500_Figa_HTML.png)
A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2) | SpringerLink
![Quality Assurance Of Radiotherapy In STRASS Trial Shows Importance Of Its Inclusion In Trial Development 2023 - EORTC Quality Assurance Of Radiotherapy In STRASS Trial Shows Importance Of Its Inclusion In Trial Development 2023 - EORTC](https://www.eortc.org/app/uploads/2017/09/tissue_900x400_2017.jpg)
Quality Assurance Of Radiotherapy In STRASS Trial Shows Importance Of Its Inclusion In Trial Development 2023 - EORTC
![Flowchart of the patients enrolled in the STRASS trial cost-utility... | Download Scientific Diagram Flowchart of the patients enrolled in the STRASS trial cost-utility... | Download Scientific Diagram](https://www.researchgate.net/publication/314645840/figure/fig1/AS:471386641702912@1489398741882/Flowchart-of-the-patients-enrolled-in-the-STRASS-trial-cost-utility-analysis-DAS.png)
Flowchart of the patients enrolled in the STRASS trial cost-utility... | Download Scientific Diagram
![Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward](https://www.mdpi.com/cancers/cancers-14-01831/article_deploy/html/images/cancers-14-01831-g001-550.jpg)
Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward
![Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/f22e5c1d-448b-454d-95ff-4672e9e383f3/gr1_lrg.gif)
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
![Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group | SpringerLink Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-014-3965-2/MediaObjects/10434_2014_3965_Fig3_HTML.gif)
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group | SpringerLink
![Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward](https://www.mdpi.com/cancers/cancers-14-01831/article_deploy/html/images/cancers-14-01831-g001.png)
Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward
SARCOMA CONNECT on Twitter: "https://t.co/WXMOZSR4zK ⚡#Sarcoma . Comparison of #STRASS and #STREXIT data published in @AnnalsofSurgery :preoperative RT associated with better ARFS in patients with #liposarcoma. #MedED #oncology" / Twitter
![Alessandro Gronchi on Twitter: "@SprakerMDPhD @ASTRO_org @TARPSWG In addition unfortunately #STRASS didn't show any LC benefit, save for the liposarcoma subgroup. And for G1-2 only. Stay tuned... #STREXIT study results (pts treated off trial by ... Alessandro Gronchi on Twitter: "@SprakerMDPhD @ASTRO_org @TARPSWG In addition unfortunately #STRASS didn't show any LC benefit, save for the liposarcoma subgroup. And for G1-2 only. Stay tuned... #STREXIT study results (pts treated off trial by ...](https://pbs.twimg.com/media/EzFe6yUWUAI5jon.jpg)